Loading Nifty 50, Nifty Bank, and Sensex…
Dr. Agarwal's Health Care Limited
AGARWALEYE · Corporate filings
NSE
Dr. Agarwal's Health Care Limited
AGARWALEYE · NSE · Healthcare
₹551.25
-0.52%
As of 12 Nov 2026
Dr. Agarwal's Health Care Limited (AGARWALEYE) is listed on NSE in the Healthcare sector. It last traded at ₹551.25, down 0.52% on the session. Its 52-week range is ₹401.00 to ₹567.75.
Research output is rule-based and informational only. It is not investment advice.
Analytics for AGARWALEYE are not available yet. Technicals, fundamentals, peer ranking
and risk notes appear here once this listing's daily history and annual filings are synced.
Financial Charts & Report
Stock market charts for Dr. Agarwal's Health Care Limited quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Results Change Summary quarter-on-quarter and year-on-year filing evidence
Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns stock, sector, and exchange benchmarks
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
Corporate Governance SEBI integrated governance filing
Loading governance disclosure...
Announcements
Market activity
Short selling - 414 shares
Market activity
Short selling - 2,292 shares
Announcement
Announcement
Announcement
Announcement
Announcement
Announcement
Market activity
Short selling - 230 shares
Market activity
Short selling - 276 shares
Market activity
Short selling - 25 shares
Announcement
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Full history
No corporate actions available right now.
Board Meetings
05 Nov 2026
Corrigendum to the Outcome of Board Meeting held on November 05, 2026, is submitted
05 Nov 2026
Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter and Half Year Ended September 30, 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
20 Oct 2026
Material Update on the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited and their respective shareholders and creditors
04 Aug 2026
Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter Ended June 30, 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
21 May 2026
Dr. Agarwal's Health Care Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.